Last updated on May 2019

Dose Response Study of EMA401 in Patients With Post-herpetic Neuralgia (PHN)


Brief description of study

To characterize dose response, and evaluate safety and efficacy of three different doses of EMA401 compared to placebo in patients with post-herpetic neuralgia (PHN)

Clinical Study Identifier: NCT03094195

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.